Legal Representation
Attorney
Michael H. Jacobs
USPTO Deadlines
Application History
16 eventsDate | Code | Type | Description |
---|---|---|---|
Oct 25, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Oct 25, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Mar 27, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
Mar 27, 2024 | GNFR | O | FINAL REFUSAL E-MAILED |
Mar 27, 2024 | CNFR | R | FINAL REFUSAL WRITTEN |
Mar 4, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Mar 4, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Mar 4, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Nov 29, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Nov 29, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Sep 5, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sep 5, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
Sep 5, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Sep 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 14, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 25, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Research and development in the fields of neurological disorders and central nervous system disorders; consulting services in the field of research and development of pharmaceutical preparations for neurological disorders and central nervous system disorders; providing medical and scientific research information in the field of pharmaceuticals for neurological disorders and central nervous system disorders; providing a web site featuring medical and scientific research information in the field of neurological disorders and central nervous system disorders
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PRECISION MEDICINES"